Brain monitoring is the process of identifying any abnormality in the functioning of the brain cells by exploring the structure and function of the brain. These are used to monitor neurological disorders such as Alzheimers, Parkinsons, epilepsy, dementia, multiple sclerosis, sleep disorder, brain tumor, and others. The process involves the use of several brain monitoring devices to track brain functions such as the velocity of blood flow in the veins and arteries in the case of epilepsy and traumatic brain injury. The global brain monitoring market generated $3,850 million in 2017, and is projected to reach $6,595 million by 2025, growing at a CAGR of 6.9% from 2018 to 2025.
The global brain monitoring market is expected to register substantial growth in the near future, owing to the increase in the geriatric population and rise in prevalence of neurological disorders. In addition, technological advancements are expected to boost the market growth during the forecast period. However, stringent government regulations and unfavorable reimbursement policies are expected to hamper the market growth during the forecast period. Conversely, untapped markets in the developing countries is expected to offer remunerative opportunities for the market players. The impact of the driving factors is expected to surpass that of the restraints.
The global brain monitoring market is segmented into product type, procedure, application, and region. By product, the market is categorized into electroencephalography (EEG) devices, magnetoencephalography (MEG) devices, transcranial Doppler (TCD) devices, intracranial pressure (ICP) monitors, cerebral oximeters, magnetic resonance imaging (MRI) devices, computerized tomography (CT) devices, positron emission tomography (PET) devices, sleep monitoring devices, electromyography (EMG) devices, and accessories. The accessories segmented in further classified into electrodes, sensors, pastes & gels, caps, cables, batteries, and others. Based on procedure, market is bifurcated invasive and non-invasive. Based on application, it is categorized into epilepsy, dementia, Parkinsons disease, Huntington's disease, headache disorders, stroke, traumatic brain injuries, sleep disorders, and other diseases. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report highlights the market dynamics to understand the global brain monitoring market and capitalize on the prevailing opportunities.
Quantitative analysis of the current market and forecasts would assist stakeholders to design business strategies accordingly.
Porter's five forces analysis examines the competitive market structure and provides a deeper understanding of the influencing factors for entry and expansion.
Pin-point analysis of geographical segments offers identification of most profitable segments to capitalize on.
KEY MARKET SEGMENTS
By Product Type
Electroencephalography (EEG) Devices
Magnetoencephalography (MEG) Devices
Transcranial Doppler (TCD) Devices
Intracranial Pressure (ICP) Monitors
Cerebral Oximeters
Magnetic Resonance Imaging (MRI) Devices
Computerized Tomography (CT) Devices
Positron Emission Tomography (PET) Devices
Sleep Monitoring Devices
Electromyography (EMG) Devices
Accessories
Electrodes
Sensors
Pastes and Gels
Caps
Cables
Batteries
Others
By Procedure
Invasive
Non-invasive
By Application
Epilepsy
Dementia
Parkinson's Disease
Huntington's Disease
Headache Disorders
Stroke
Traumatic Brain Injuries
Sleep Disorders
Other Diseases
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
Spain
Italy
UK
Rest of Europe
Asia-Pacific
Australia
Japan
India
China
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY MARKET PLAYERS
Advanced Brain Monitoring, Inc.
CAS Medical Systems, Inc.
Compumedics Ltd.
General Electric Company (GE Healthcare)
Koninklijke Philips N.V. (Philips Healthcare)
Medtronic Plc.
Natus Medical Incorporated
Neural Analytics, Inc.
Siemens AG
The other players in the value chain include (profiles not included in the report):
Cadwell Laboratories
Neurosoft Limited
Elekta A.B.
InfraSacn, Inc.
BrainScope Company, Inc.
Chapter: 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
Chapter: 2: EXECUTIVE SUMMARY
2.1. CXO perspective
Chapter: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top player positioning, 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in the geriatric population
3.4.1.2. Increase in prevalence of neurological disorders
3.4.1.3. Technological advancements
3.4.2. Restraints
3.4.2.1. Stringent government regulations
3.4.2.2. Unfavorable reimbursement policies
3.4.3. Opportunity
3.4.3.1. Untapped markets in developing countries
Chapter: 4: BRAIN MONITORING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Electroencephalography devices (EEG)
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Magnetoencephalography devices (MEG)
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Transcranial Doppler devices (TCD)
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Intracranial pressure monitors (ICP)
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Cerebral oximeters
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country
4.7. Electromyography devices
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country
4.8. Magnetic resonance imaging devices (MRI)
4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast
4.8.3. Market analysis, by country
4.9. Computerized tomography devices (CT)
4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast
4.9.3. Market analysis, by country
4.10. Positron emission tomography devices (PET)
4.10.1. Key market trends, growth factors, and opportunities
4.10.2. Market size and forecast
4.10.3. Market analysis, by country
4.11. Sleep monitoring devices
4.11.1. Key market trends, growth factors, and opportunities
4.11.2. Market size and forecast
4.11.3. Market analysis, by country
4.12. Accessories
4.12.1. Key market trends, growth factors, and opportunities
4.12.1.1. Electrodes
4.12.1.2. Sensors
4.12.1.3. Paste & Gels
4.12.1.4. Caps
4.12.1.5. Cables
4.12.1.6. Batteries
4.12.1.7. Others
4.12.2. Market size and forecast, by region
4.12.3. Market analysis, by country
4.13. Other brain monitoring devices
4.13.1. Key market trends, growth factors, and opportunities
4.13.2. Market size and forecast
4.13.3. Market analysis, by country
Chapter: 5: BRAIN MONITORING MARKET, BY PROCEDURE
5.1. Overview
5.1.1. Market size and forecast
5.2. Invasive
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Non-invasive
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
Chapter: 6: BRAIN MONITORING MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Epilepsy
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Dementia
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Parkinsons Disease
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Huntington's Disease
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
6.6. Headache Disorders
6.6.1. Market size and forecast
6.6.2. Market analysis, by country
6.7. Stroke
6.7.1. Market size and forecast
6.7.2. Market analysis, by country
6.8. Traumatic Brain Injuries
6.8.1. Market size and forecast
6.8.2. Market analysis, by country
6.9. Sleep Disorders
6.9.1. Market size and forecast
6.9.2. Market analysis, by country
6.10. Other Diseases
6.10.1. Market size and forecast
6.10.2. Market analysis, by country
Chapter: 7: BRAIN MONITORING MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by product type
7.2.3. Market size and forecast, by procedure
7.2.4. Market size and forecast, by application
7.2.5. North America market size and forecast, by country
7.2.5.1. U.S. market size and forecast, by product type
7.2.5.2. U.S. market size and forecast, by procedure
7.2.5.3. U.S. market size and forecast, by application
7.2.5.4. Canada market size and forecast, by product type
7.2.5.5. Canada market size and forecast, by procedure
7.2.5.6. Canada market size and forecast, by application
7.2.5.7. Mexico market size and forecast, by product type
7.2.5.8. Mexico market size and forecast, by procedure
7.2.5.9. Mexico market size and forecast, by application
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by product type
7.3.3. Market size and forecast, by procedure
7.3.4. Market size and forecast, by application
7.3.5. Europe market size and forecast, by country
7.3.5.1. Germany market size and forecast, by product type
7.3.5.2. Germany market size and forecast, by procedure
7.3.5.3. Germany market size and forecast, by application
7.3.5.4. France market size and forecast, by product type
7.3.5.5. France market size and forecast, by procedure
7.3.5.6. France market size and forecast, by application
7.3.5.7. UK market size and forecast, by product type
7.3.5.8. UK market size and forecast, by procedure
7.3.5.9. UK market size and forecast, by application
7.3.5.10. Italy market size and forecast, by product type
7.3.5.11. Italy market size and forecast, by procedure
7.3.5.12. Italy market size and forecast, by application
7.3.5.13. Spain market size and forecast, by product type
7.3.5.14. Spain market size and forecast, by procedure
7.3.5.15. Spain market size and forecast, by application
7.3.5.16. Rest of Europe market size and forecast, by product type
7.3.5.17. Rest of Europe market size and forecast, by procedure
7.3.5.18. Rest of Europe market size and forecast, by application
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by product type
7.4.3. Market size and forecast, by procedure
7.4.4. Market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by country
7.4.5.1. Japan market size and forecast, by product type
7.4.5.2. Japan market size and forecast, by procedure
7.4.5.3. Japan market size and forecast, by application
7.4.5.4. China market size and forecast, by product type
7.4.5.5. China market size and forecast, by procedure
7.4.5.6. China market size and forecast, by application
7.4.5.7. Australia market size and forecast, by product type
7.4.5.8. Australia market size and forecast, by procedure
7.4.5.9. Australia market size and forecast, by application
7.4.5.10. India market size and forecast, by product type
7.4.5.11. India market size and forecast, by procedure
7.4.5.12. India market size and forecast, by application
7.4.5.13. Rest of Asia-Pacific market size and forecast, by product type
7.4.5.14. Rest of Asia-Pacific market size and forecast, by procedure
7.4.5.15. Rest of Asia-Pacific market size and forecast, by application
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by product type
7.5.3. Market size and forecast, by procedure
7.5.4. Market size and forecast, by application
7.5.5. LAMEA market size and forecast, by country
7.5.5.1. Brazil market size and forecast, by product type
7.5.5.2. Brazil market size and forecast, by procedure
7.5.5.3. Brazil market size and forecast, by application
7.5.5.4. Saudi Arabia market size and forecast, by product type
7.5.5.5. Saudi Arabia market size and forecast, by procedure
7.5.5.6. Saudi Arabia market size and forecast, by application
7.5.5.7. South Africa market size and forecast, by product type
7.5.5.8. South Africa market size and forecast, by procedure
7.5.5.9. South Africa market size and forecast, by application
7.5.5.10. Rest of LAMEA market size and forecast, by product type
7.5.5.11. Rest of LAMEA market size and forecast, by procedure
7.5.5.12. Rest of LAMEA market size and forecast, by application
Chapter: 8: COMPANY PROFILES
8.1. ADVANCED BRAIN MONITORING, INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.2. CAS MEDICAL SYSTEMS, INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Product portfolio
8.2.4. Business performance
8.3. COMPUMEDICS LTD.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product Portfolio
8.3.5. Business performance
8.4. GENERAL ELECTRIC COMPANY (GE HEALTHCARE)
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. MEDTRONIC PLC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. NATUS MEDICAL INCORPORATED
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. NEURAL ANALYTICS, INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments
8.9. NIHON KOHDEN CORPORATION
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. SIEMENS AG
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance